Naperville, IL -- (SBWIRE) -- 07/17/2012 -- The Blood Glucose Monitoring Device market in the US is expected to grow at a CAGR of 3.8 percent over the period 2011-2011. One of the key factors contributing to this market growth is the introduction of personal testing kits. The Blood Glucose Monitoring Device market in the US has also witnessed the adoption of continuous glucose monitoring systems. However, the unwillingness of diabetes patients to use blood glucose monitoring devices could pose a challenge to the growth of this market.
The Blood Glucose Monitoring Device Market in the US 2011-2015 report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the US market; it also covers the Blood Glucose Test Strips, Blood Glucose Meters, and Lancets market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Bayer Healthcare, LifeScan Inc., Medtronic Inc., and Roche Diagnostics. Other vendors mentioned in the report: Abbott Laboratories, Arkray Inc., Braun Melsungen AG, Dexcom, GlySens Inc., Hainice Medical Inc., Nipro, Diagnostics Inc., Nova Biomedical, and Terumo Corporation.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
To view a detailed table of contents for this market report please visit: http://www.reportstack.com/product/86134/blood-glucose-monitoring-market-in-the-us-2011-2015.html